Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.03 USD | -0.14% | -4.95% | -2.64% |
Jun. 11 | GSK Starts Appeal Against US State Court Ruling on Zantac Lawsuit | MT |
Jun. 11 | GSK Starts Appeal Process Against Delaware Court Decision Allowing Expert Testimonies in Zantac Litigation | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.64% | 159B | |
+48.53% | 780B | |
+40.67% | 627B | |
-6.37% | 353B | |
+20.93% | 334B | |
+8.21% | 296B | |
+16.75% | 244B | |
-1.19% | 217B | |
+10.85% | 214B | |
+4.40% | 161B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer Says Phase 3 Trial of Abrysvo for Respiratory Syncytial Virus Disease Meets Primary Endpoints